Lonza and CN Bio entered into a distribution agreement under which Lonza will supply hepatic cells to be prequalified by CN Bio for use in their PhysioMimix Single-and Multi-Organ MPS to help transform the way human-relevant preclinical data is generated. With prequalified cells, customers can avoid having to trial numerous cell types in order to find ones that will grow and behave functionally in 3D culture, aiding in generating reliable and robust data.   Maureen Bunger, Senior Product Manag...